Association between adiponectin, resistin, insulin resistance, and colorectal tumors (original) (raw)

References

1. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33–64
   Article CAS PubMed Google Scholar
2. Singh PN, Fraser GE (1998) Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol 148:761–774
   CAS PubMed Google Scholar
3. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD (1997) Energy balance and colon cancer—beyond physical activity. Cancer Res 57:75–80
   CAS PubMed Google Scholar
4. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH (2006) Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106:2376–2381
   Article CAS PubMed Google Scholar
5. Chasan-Taber S, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci E, Ascherio A, Willett WC (1996) Reproducibility and validity of a self-administered physical activity questionnaire for male health profesionals. Epidemiology 7:81–86
   Article CAS PubMed Google Scholar
6. Lee IM, Sesso HD, Paffenbarger RS Jr (1999) Physical activity and risk of lung cancer. Int J Epidemiol 28:620–625
   Article CAS PubMed Google Scholar
7. Kershaw EE, Flier JSJ (2004) Adipose tissue as an endocrine organ. Clin Endocrinol Metab 6:2548–2556
   Google Scholar
8. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN (1992) Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167:1317–1325
   CAS PubMed Google Scholar
9. Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 1:277–282
   Google Scholar
10. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919
    Article CAS PubMed Google Scholar
11. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769
    Article CAS PubMed Google Scholar
12. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767–2770
    Article CAS PubMed Google Scholar
13. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9:5699–5704
    CAS PubMed Google Scholar
14. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:1688–1694
    Article CAS PubMed Google Scholar
15. Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P (2006) Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 15:401–402
    Article CAS PubMed Google Scholar
16. Diez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300
    Article CAS PubMed Google Scholar
17. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83
    Article CAS PubMed Google Scholar
18. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595–1599
    CAS PubMed Google Scholar
19. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM (2002) Plasma adiponectin levels in overweight and obese Asians. Obes Res 10:1104–1110
    Article CAS PubMed Google Scholar
20. Karapanagiotou EM, Tsochatzis EA, Dilana KD (2008) The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer. Lung Cancer 61:391–397
    Article PubMed Google Scholar
21. Kang JH, Yu BY, Youn DS (2007) Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 22:117–121
    Article CAS PubMed Google Scholar
22. Kumor A, Daniel P, Pietruczuk M, Małecka-Panas E (2009) Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24:275–278
    Article PubMed Google Scholar
23. Eraslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N (2009) Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 54:862–868
    Article CAS Google Scholar
24. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:45
    Article CAS Google Scholar
25. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935
    Article CAS PubMed Google Scholar
26. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312
    Article CAS PubMed Google Scholar
27. Nagaev I, Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561–564
    Article CAS PubMed Google Scholar
28. TNM classification of malignant tumours. Sobin L.H, Wittekind Ch. Sixth Edition, 2002
29. Gordon ME, McKeever KH (2005) Diurnal variation of ghrelin, leptin, and adiponectin in standardbred mares. J Anim Sci 10:2365–2371
    Google Scholar
30. Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J (2004) Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. PNAS 101:10434–10439
    Article CAS PubMed Google Scholar
31. Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL, Mantzoros CS (2003) Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 6:2838–2843
    Article CAS Google Scholar
32. Oliver P, Ribot J, Rodríguez AM, Sánchez J, Picó C, Palou A (2006) Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm. Pflugers Arch 3:260–267
    Article CAS Google Scholar
33. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407
    Article CAS PubMed Google Scholar
34. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F (2001) Risk factors and life expectancy research group. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10:937–941
    CAS PubMed Google Scholar
35. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221–1225
    Article CAS PubMed Google Scholar
36. Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 101:2476–2481
    Article PubMed CAS Google Scholar
37. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723–1732
    CAS PubMed Google Scholar
38. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Inamori M, Nakajima N, Watanabe M, Kubota N, Yamauchi T, Kadowaki T, Wada K, Nakagama H, Nakajima A (2008) Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57:1531–1538
    Article CAS PubMed Google Scholar
39. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H (2005) Plasma adiponectin and gastric cancer. Clin Cancer Res 11:466–472
    Article CAS PubMed Google Scholar
40. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S (2005) Prostate cancer and adiponectin. Urology 65:1168–1172
    Article PubMed Google Scholar
41. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102–1107
    Article CAS PubMed Google Scholar
42. Ferroni P, Palmirotta R, Spila A, Martini F, Formica V, Portarena I, Del Monte G, Buonomo O, Roselli M, Guadagni F (2007) Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 27:483–489
    CAS PubMed Google Scholar
43. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 9:2094–2099
    Article Google Scholar
44. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932–939
    Article CAS PubMed Google Scholar
45. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314:415–419
    Article CAS PubMed Google Scholar
46. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556
    Article CAS PubMed Google Scholar
47. Utzschneider KM, Carr DB, Tong J, Wallace TM, Hull RL, Zraika S, Xiao Q, Mistry JS, Retzlaff BM, Knopp RH, Kahn SE (2005) Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48:2330–2333
    Article CAS PubMed Google Scholar
48. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Mantzoros CS (2003) Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11:1048–1054
    Article CAS PubMed Google Scholar
49. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, Park KS (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150–156
    Article CAS PubMed Google Scholar
50. Shacter E, Weitzman SA (2002) Chronic inflammation and cancer. Oncology 16:217–226
    PubMed Google Scholar

Download references